Technical Articles
tumor immunotherapy
Study on the Role of IL-21/IL-21R Signaling Pathway in Tumor Immunotherapy Based on TR-FRET Technology
2026-04-09IL-21 protein is one of the major immunomodulators, regulating various immune responses by influencing multiple immune cells. This protein belongs to the type I cytokine family and exhibits pleiotropic effects in tumor immunotherapy.
View details
- Cancer
- TR-FRET Technology
- IL-21/IL-21R
- Tumor Immunotherapy
The role and mechanism of IL-21 protein in tumor immunotherapy and its prospects for combination therapy
2026-04-02IL-21 protein belongs to the IL-2 cytokine superfamily and is primarily produced by CD4-positive T cells. It can also be partially secreted by natural killer T cells, follicular helper T cells, and CD8-positive T cells, with some lymphoid hematopoietic cells capable of producing it in small amounts.
View details
- Cancer
- IL-21 Protein
- Tumor Immunotherapy
- T Cells
IL-33: Can It Become the Next Target for Tumor Immunotherapy?
2025-09-16IL-33 is a member of the interleukin-1 cytokine family, initially named DVS27. It is constitutively expressed in barrier tissue cells of various organs, and its specific receptor is suppression of tumorigenicity 2 (ST2).
View details
- Cancer
- IL-33
- tumor immunotherapy
- Interleukin-1
- 1
Link：
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy 
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
Business license (three certificates in one) Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.
